cancer therapeutics (University of Oslo/Inven2)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecancer therapeutics (University of Oslo/Inven2)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypoxiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oslo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInven2University Of Oslo
Active IndicationsN/A
Inactive IndicationsHypoxiaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A